EVFM — Evofem Biosciences Share News
0.000.00%
Last trade - 00:00- $0.83m
- $59.92m
- $20.18m
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting
Brief: Evofem Expects Significant Reduction In PHEXXI Manufacturing Cost Through Agreement With Windtree Therapeutics
Windtree Therapeutics rises on licensing deal for birth control vaginal gel
Brief: Aditxt Provides Update On Equity Line Of Credit, ATM Usage, And Outstanding Number Of Shares
Brief: Evofem Secures Investor Support For Proposed Merger Through Voting Agreements
Brief: Aditxt Completes Third Parent Equity Investment Under Amended And Restated Merger Agreement With Evofem
Brief: Aditxt Says Will Provide $1.5 Mln Of Financing By Sept 30, Additional $1.5 Mln By Oct 31
Brief: Aditxt And Evofem Amend And Restate Merger Agreement, Targeting September 30 Closing
Brief: Lupin- Divests U.S. Commercial Women's Health Specialty Business To Evofem
Brief: Aditxt Enters Into Agreement To Acquire Evofem Biosciences To Address Diverse Reproductive Health Needs Of Women Globally
Brief: Evofem Biosciences Signs Letter Of Intent To Enable Listing On A National Stock Exchange
Brief: Evofem Appoints Ivy Zhang As Chief Financial Officer And Secretary
Brief: Evofem Wins Phexxi Coverage With Largest Payer In New York With No Prior Authorization Required
Brief: Evofem Biosciences Inc To Reduce Its Current Workforce Resulting In An Overall 39% Reduction Of Payroll Expenses
Brief: Evofem Biosciences Appoints Interim Chief Financial Officer
Brief: Evofem To Explore Strategic Alternatives To Maximize Shareholder Value